Related Experiment Video
Updated: May 23, 2026
08:36
In Vivo Imaging to Measure Spontaneous Lung Metastasis of Orthotopically-injected Breast Tumor Cells
Published on: June 23, 2022
Premetastatic niche: ready for new therapeutic interventions?
Alice Zoccoli1, Michele Iuliani, Francesco Pantano
1Campus Bio-Medico University, Department of Medical Oncology, Rome, Italy.
Expert Opinion on Therapeutic Targets
|March 27, 2012
Summary
Bone marrow-derived cells create premetastatic niches, facilitating tumor cell spread. Targeting these niches offers a new therapeutic strategy for bone metastases.
Area of Science:
- Oncology
- Cancer Metastasis Research
Background:
- Bone marrow-derived cells (BMDC) establish premetastatic niches via chemokine and integrin signaling.
- These niches precede tumor cell arrival, aiding metastasis.
- Cancer stem cells (CSCs) exhibit high metastatic potential, influenced by pathways like SHH, FOXM1, and Notch.
Purpose of the Study:
- To summarize the molecular mechanisms underlying premetastatic niche formation.
- To highlight the role of BMDC and signaling pathways in metastasis.
Main Methods:
- This is a review article.
- Molecular mechanisms of premetastatic niche onset are summarized.
Main Results:
- Premetastatic niches are fertile microenvironments promoting tumor cell invasion, survival, and proliferation.
- These niches represent a novel mechanism for metastasis promotion.
Conclusions:
- Targeting the premetastatic niche presents a promising therapeutic avenue.
- This approach could be particularly effective for treating bone metastases.
Related Concept Videos
02:30Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...